Efficacy of Bacillus thuringiensis var. israelensis (Bti VectoBac® 5000 ITU/mg) Serotype H-14 Technical powder, (Valent Biosciences corp; Illinois, USA) was evaluated for the control of late third-instar laboratory reared Anopheles stephensi an Asian vector and field collected Culex quinquefasciatus larvae from Lahore, Pakistan. The primary objective was to determine the minimum effective dose of this formulation for larvicidal activity against these mosquitoes, Preliminary laboratory bioassay revealed, significant larval mortality of the main malaria vector species A. stephensi and field collected Culex quinquefasciatus with this larvicide. In general field collected Culex quinquefasciatus was found 1OX more susceptible as compared to laboratory reared A. stephensi. LC50 was 0.00248 ppm for Culex quinquefasciatus as compared to 0.02469 ppm for laboratory reared A. stephensi after 48 hours exposure. It is concluded that Asian malaria vector A. stephensi and Culex quinquefasciatus are highly susceptible to Bti TP. However. Field investigations are required to evaluate it in natural conditions.